Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.

Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J.

J Neuroinflammation. 2014 Jun 11;11:103. doi: 10.1186/1742-2094-11-103.

2.

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.

Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelsö C, Zetterberg H, Hagberg L.

BMC Neurol. 2013 Jan 7;13:2. doi: 10.1186/1471-2377-13-2.

3.

[CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].

Rupprecht TA, Lechner C, Tumani H, Fingerle V.

Nervenarzt. 2014 Apr;85(4):459-64. doi: 10.1007/s00115-014-4020-z. German.

PMID:
24682168
4.

CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Ljøstad U, Mygland A.

J Neurol. 2008 May;255(5):732-7. doi: 10.1007/s00415-008-0785-y. Epub 2008 Mar 17. Erratum in: J Neurol. 2008 May;255(5):782.

PMID:
18344056
5.

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.

Dersch R, Hottenrott T, Senel M, Lehmensiek V, Tumani H, Rauer S, Stich O.

Fluids Barriers CNS. 2015 May 15;12:12. doi: 10.1186/s12987-015-0008-8.

6.

Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.

Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.

Scand J Infect Dis. 2013 Jul;45(7):526-30. doi: 10.3109/00365548.2013.776700. Epub 2013 Mar 22.

PMID:
23521134
7.

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, Klein M, Pfister HW, Koedel U.

J Neuroinflammation. 2009 Dec 30;6:42. doi: 10.1186/1742-2094-6-42.

8.

Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.

van Burgel ND, Bakels F, Kroes AC, van Dam AP.

J Clin Microbiol. 2011 May;49(5):2027-30. doi: 10.1128/JCM.00084-11. Epub 2011 Mar 2.

9.

CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.

Borde JP, Meier S, Fingerle V, Klier C, Hübner J, Kern WV.

BMC Infect Dis. 2012 Dec 10;12:344. doi: 10.1186/1471-2334-12-344.

10.

A prospective study on the role of CXCL13 in Lyme neuroborreliosis.

Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA.

Neurology. 2011 Mar 22;76(12):1051-8. doi: 10.1212/WNL.0b013e318211c39a.

PMID:
21422457
11.

The chemokine CXCL13 in acute neuroborreliosis.

Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J.

J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):929-33. doi: 10.1136/jnnp.2009.195438. Epub 2009 Dec 3. Erratum in: J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1177.

PMID:
19965843
12.

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.

Kowarik MC, Cepok S, Sellner J, Grummel V, Weber MS, Korn T, Berthele A, Hemmer B.

J Neuroinflammation. 2012 May 16;9:93. doi: 10.1186/1742-2094-9-93.

13.

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.

Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J.

J Infect. 2011 Feb;62(2):149-58. doi: 10.1016/j.jinf.2010.11.005. Epub 2010 Nov 16.

PMID:
21087629
14.

Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.

Kępa L, Oczko-Grzesik B, Sobala-Szczygieł B, Boroń-Kaczmarska A.

Przegl Epidemiol. 2015;69(4):705-10, 851-5. English, Polish.

15.

Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.

Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H, Nau R, Schmidt H.

J Neurol. 2012 Apr;259(4):630-6. doi: 10.1007/s00415-011-6221-8. Epub 2011 Sep 6.

16.

CXCL13 chemokine in pediatric and adult neuroborreliosis.

Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E.

Acta Neurol Scand. 2011 Nov;124(5):321-8. doi: 10.1111/j.1600-0404.2010.01477.x. Epub 2011 Feb 15.

PMID:
21320077
17.

Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.

Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J.

JAMA Neurol. 2015 Feb;72(2):180-6. doi: 10.1001/jamaneurol.2014.2956.

18.

Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

Cerar T, Ogrinc K, Lotric-Furlan S, Kobal J, Levicnik-Stezinar S, Strle F, Ruzić-Sabljic E.

Clin Vaccine Immunol. 2013 Oct;20(10):1578-84. doi: 10.1128/CVI.00353-13. Epub 2013 Aug 14.

19.

High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.

van Burgel ND, Brandenburg A, Gerritsen HJ, Kroes AC, van Dam AP.

Clin Microbiol Infect. 2011 Oct;17(10):1495-500. doi: 10.1111/j.1469-0691.2011.03459.x. Epub 2011 Mar 7.

20.

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.

Wutte N, Archelos J, Crowe BA, Zenz W, Daghofer E, Fazekas F, Aberer E.

J Neurol Sci. 2014 Dec 15;347(1-2):96-103. doi: 10.1016/j.jns.2014.09.027. Epub 2014 Sep 26.

PMID:
25288328
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk